Furmark T, Tillfors M, Garpenstrand H, Marteinsdottir I, Langstrom B, Oreland L et al. Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neurosci Lett 362: 189-192

Department of Psychology, Uppsala University, Uppsala, Sweden.
Neuroscience Letters (Impact Factor: 2.03). 06/2004; 362(3):189-92. DOI: 10.1016/j.neulet.2004.02.070
Source: PubMed


A functional polymorphism in the promoter region of the human serotonin transporter (5-HTT) gene has been related to negative affect and amygdala activity. We studied amygdala activation during social anxiety provocation in relation to affective ratings and 5-HTT genetic variation. [H2(15)O]positron emission tomography was used to estimate amygdala blood flow during private and public speaking (baseline and anxiety conditions) in 17 patients with social phobia. Genotyping identified patients with long and short alleles in the promoter region of the 5-HTT. Individuals with one or two copies of the short allele exhibited significantly increased levels of anxiety-related traits, state anxiety, and enhanced right amygdala responding to anxiety provocation, compared with subjects homozygous for the long allele. Thus, 5-HTT genetic variation was associated with symptom severity and amygdala excitability in social phobia.

Download full-text


Available from: Tomas Furmark, Mar 17, 2015
  • Source
    • "The short form has been associated with a reduced transcriptional efficiency of SLC6A4, resulting in decrease SLC6A4 expression and serotonin reuptake compared to the long form (Lesch et al., 1996; Gerretsen and Pollock, 2008). The short form has also been associated with the presence of social phobia (Furmark et al., 2004), obsessive-compulsive disorder (Hasler et al., 2006), posttraumatic stress disorder and depression (Kilpatrick et al., 2007), and with anxiety-related traits such as neuroticism and danger avoidance (Lesch et al., 1996). However, a meta-analysis did not confirm the association of the short form with depression (Risch et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Environmental effects and personal experiences could be expressed in individuals through epigenetic non-structural changes such as DNA methylation. This methylation could up- regulate or down-regulate corresponding gene expressions and modify related phenotypes. DNA methylation increases with aging and could be related to the late expression of some forms of mental disease. The objective of this study was to evaluate the association between anxiety disorders and/or depression in older women and DNA methylation for four genes related to anxiety or depression. Women aged 65 and older with (n = 19) or without (n = 24) anxiety disorders and/or major depressive episode (DSM-IV), were recruited. DNA methylation and single nucleotide variant (SNV) were evaluated from saliva, respectively by pyrosequencing and by PCR, for the following genes: brain-derived neurotrophic factor (BDNF; rs6265), oxytocin receptor (OXTR; rs53576), serotonin transporter (SLC6A4; rs25531), and apolipoprotein E (APOE; rs429358 and rs7412). A greater BDNF DNA methylation was observed in subjects with anxiety/depression compared to control group subjects (Mean: 2.92 SD ± 0.74 vs. 2.34 ± 0.42; p= 0.0026). This difference was more pronounced in subjects carrying the BDNF rs6265 CT genotype (2.99 ± 0.41 vs. 2.27 ± 0.26; p= 0.0006) than those carrying the CC genotype (p= 0.0332); no subjects with the TT genotype were observed. For OXTR, a greater DNA methylation was observed in subjects with anxiety/depression, but only for those carrying the AA genotype of the OXTR rs53576 SNV, more particularly at one out of the seven CpGs studied (7.01 ± 0.94 vs. 4.44 ± 1.11; p= 0.0063). No significant differences were observed for APOE and SLC6A4. These results suggest that DNA methylation in interaction with SNV variations in BDNF and OXTR, are associated with the occurrence of anxiety/depression in older women.
    Full-text · Article · Jun 2015 · Frontiers in Genetics
  • Source
    • "Several studies suggest that these variants might modulate a wide range emotional and behavioral disturbances [25]. In the field of SAD, studies with clinical samples have reported an association between the 5-HTTLPR with increased levels of anxiety-related traits, SAD severity and greater amygdala excitability in response symptom provocation [29], to amygdala hyper-responsivness in response to threat faces [30], and to alterations in insula activation to threat [31]. However, to our knowledge, differences in functional variant of the serotonin transporter have not been previously studied in the impulsiveinhibited subtypes of SAD. "
    [Show abstract] [Hide abstract]
    ABSTRACT: To study qualitatively different subgroups of social anxiety disorder (SAD) based on harm avoidance (HA) and novelty seeking (NS) dimensions. One hundred and forty-two university students with SAD (SCID-DSM-IV) were included in the study. The temperament dimensions HA and NS from the Cloninger's Temperament and Character Inventory were subjected to cluster analysis to identify meaningful subgroups. The identified subgroups were compared for sociodemographics, SAD severity, substance use, history of suicide and self-harm attempts, early life events, and two serotonin transporter gene polymorphisms (5-HTTLPR and STin2.VNTR). Two subgroups of SAD were identified by cluster analysis: a larger (61% of the sample) inhibited subgroup of subjects with "high-HA/low-NS", and a smaller (39%) atypical impulsive subgroup with high-moderate HA and NS. The two groups did not differ in social anxiety severity, but did differ in history of lifetime impulsive-related-problems. History of suicide attempts and self-harm were as twice as frequent in the impulsive subgroup. Significant differences were observed in the pattern of substance misuse. Whereas subjects in the inhibited subgroup showed a greater use of alcohol (P=0.002), subjects in the impulsive subgroup showed a greater use of substances with a high-sensation-seeking profile (P<0.001). The STin2.VNTR genotype frequency showed an inverse distribution between subgroups (P=0.005). Our study provides further evidence for the presence of qualitatively different SAD subgroups and the propensity of a subset of people with SAD to exhibit impulsive, high-risk behaviors. Copyright © 2014 Elsevier Masson SAS. All rights reserved.
    Full-text · Article · Dec 2014 · European Psychiatry
  • Source
    • "The s-allele of 5-HTTLPR is associated with reduction of serotonin uptake and 5-HTT expression [18]. Having the s-allele is associated with increased amygdala reactivity [10], [19]–[21] and poorer treatment response to selective serotonin reuptake inhibitors (SSRIs) for social anxiety disorder (SAD) [22] and panic disorder [23]. In another study persistent higher symptoms in panic disorder patients carrying either an s-allele or an LG-allele, were reported by Lonsdorf et al. [24]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The role of genetics for predicting the response to cognitive behavior therapy (CBT) for social anxiety disorder (SAD) has only been studied in one previous investigation. The serotonin transporter (5-HTTLPR), the catechol-o-methyltransferase (COMT) val158met, and the tryptophan hydroxylase-2 (TPH2) G-703Tpolymorphisms are implicated in the regulation of amygdala reactivity and fear extinction and therefore might be of relevance for CBT outcome. The aim of the present study was to investigate if these three gene variants predicted response to CBT in a large sample of SAD patients. Participants were recruited from two separate randomized controlled CBT trials (trial 1: n = 112, trial 2: n = 202). Genotyping were performed on DNA extracted from blood or saliva samples. Effects were analyzed at follow-up (6 or 12 months after treatment) for both groups and for each group separately at post-treatment. The main outcome measure was the Liebowitz Social Anxiety Scale Self-Report. At long-term follow-up, there was no effect of any genotype, or gene × gene interactions, on treatment response. In the subsamples, there was time by genotype interaction effects indicating an influence of the TPH2 G-703T-polymorphism on CBT short-term response, however the direction of the effect was not consistent across trials. None of the three gene variants, 5-HTTLPR, COMTval158met and TPH2 G-703T, was associated with long-term response to CBT for SAD. (ID-NCT0056496).
    Full-text · Article · Nov 2013 · PLoS ONE
Show more